# Riverview Bancorp Inc: financial statements, quarterly

RVSB · Nasdaq · CIK 1041368 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/rvsb.md) · [Financials](/companies/rvsb/financials.md) · [Filings](/companies/rvsb/filings.md) · [Insiders](/companies/rvsb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rvsb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [4,184](/filings/0000939057-24-000163.md) | [4,948](/filings/0000939057-24-000163.md) | [5,739](/filings/0000939057-24-000163.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [697](/filings/0000939057-25-000159.md) | [377](/filings/0000939057-25-000159.md) | [(1,095)](/filings/0000939057-25-000159.md) | [253](/filings/0001041368-26-000007.md) | [425](/filings/0001041368-26-000007.md) | [343](/filings/0001041368-26-000007.md) | [314](/filings/0001041368-26-000007.md) | [322](/filings/0001104659-26-096729.md) | [296](/filings/0001041368-26-000007.md) | [363](/filings/0001041368-26-000007.md) | [(2,474)](/filings/0001041368-26-000007.md) | [435](/filings/0001104659-26-096729.md) |
| Net income | $k | [2,472](/filings/0000939057-25-000159.md) | [1,452](/filings/0000939057-25-000159.md) | [(2,968)](/filings/0000939057-25-000159.md) | [966](/filings/0001041368-26-000007.md) | [1,557](/filings/0001041368-26-000007.md) | [1,232](/filings/0001041368-26-000007.md) | [1,148](/filings/0001041368-26-000007.md) | [1,225](/filings/0001104659-26-096729.md) | [1,099](/filings/0001041368-26-000007.md) | [1,377](/filings/0001041368-26-000007.md) | [(8,042)](/filings/0001041368-26-000007.md) | [1,694](/filings/0001104659-26-096729.md) |
| Diluted EPS | $ per share | [0.12](/filings/0000939057-25-000159.md) | [0.07](/filings/0000939057-25-000159.md) | [(0.14)](/filings/0000939057-25-000159.md) | [0.05](/filings/0001041368-26-000007.md) | [0.07](/filings/0001041368-26-000007.md) | [0.06](/filings/0001041368-26-000007.md) | [0.05](/filings/0001041368-26-000007.md) | [0.06](/filings/0001104659-26-096729.md) | [0.05](/filings/0001041368-26-000007.md) | [0.07](/filings/0001041368-26-000007.md) | [(0.39)](/filings/0001041368-26-000007.md) | [0.08](/filings/0001104659-26-096729.md) |
| Basic EPS | $ per share | [0.12](/filings/0000939057-25-000159.md) | [0.07](/filings/0000939057-25-000159.md) | [(0.14)](/filings/0000939057-25-000159.md) | [0.05](/filings/0001041368-26-000007.md) | [0.07](/filings/0001041368-26-000007.md) | [0.06](/filings/0001041368-26-000007.md) | [0.05](/filings/0001041368-26-000007.md) | [0.06](/filings/0001104659-26-096729.md) | [0.05](/filings/0001041368-26-000007.md) | [0.07](/filings/0001041368-26-000007.md) | [(0.39)](/filings/0001041368-26-000007.md) | [0.08](/filings/0001104659-26-096729.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [30.9](/filings/0000939057-23-000343.md) | [37.6](/filings/0000939057-24-000051.md) | [23.6](/filings/0000939057-25-000159.md) | [27.8](/filings/0000939057-24-000208.md) | [31.0](/filings/0000939057-24-000317.md) | [25.3](/filings/0000939057-25-000048.md) | [29.4](/filings/0001041368-26-000007.md) | [34.2](/filings/0000939057-25-000203.md) | [32.8](/filings/0001041368-25-000004.md) | [28.6](/filings/0001041368-26-000003.md) | [117](/filings/0001104659-26-096729.md) | [102](/filings/0001104659-26-096729.md) |
| Total assets | $m | [1,584](/filings/0000939057-23-000343.md) | [1,591](/filings/0000939057-24-000051.md) | [1,522](/filings/0000939057-25-000159.md) | [1,538](/filings/0000939057-24-000208.md) | [1,548](/filings/0000939057-24-000317.md) | [1,509](/filings/0000939057-25-000048.md) | [1,513](/filings/0001041368-26-000007.md) | [1,517](/filings/0000939057-25-000203.md) | [1,510](/filings/0001041368-25-000004.md) | [1,512](/filings/0001041368-26-000003.md) | [1,464](/filings/0001104659-26-096729.md) | [1,471](/filings/0001104659-26-096729.md) |
| Total liabilities | $m | [1,432](/filings/0000939057-23-000343.md) | [1,432](/filings/0000939057-24-000051.md) | [1,366](/filings/0000939057-25-000159.md) | [1,382](/filings/0000939057-24-000208.md) | [1,388](/filings/0000939057-24-000317.md) | [1,350](/filings/0000939057-25-000048.md) | [1,353](/filings/0001041368-26-000007.md) | [1,355](/filings/0000939057-25-000203.md) | [1,346](/filings/0001041368-25-000004.md) | [1,348](/filings/0001041368-26-000003.md) | [1,318](/filings/0001104659-26-096729.md) | [1,326](/filings/0001104659-26-096729.md) |
| Shareholders' equity | $m | [152](/filings/0000939057-23-000343.md) | [158](/filings/0000939057-24-000051.md) | [156](/filings/0000939057-25-000159.md) | [156](/filings/0000939057-24-000208.md) | [161](/filings/0000939057-24-000317.md) | [158](/filings/0000939057-25-000048.md) | [160](/filings/0001041368-26-000007.md) | [162](/filings/0000939057-25-000203.md) | [164](/filings/0001041368-25-000004.md) | [164](/filings/0001041368-26-000003.md) | [146](/filings/0001104659-26-096729.md) | [145](/filings/0001104659-26-096729.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.5 d](/filings/0000939057-24-000317.md) | [10.1 d](/filings/0000939057-25-000048.md) | [(7.9) d](/filings/0001041368-26-000007.md) | [5.4](/filings/0000939057-25-000203.md) | [0.8 d](/filings/0001041368-25-000004.md) | [2.2 d](/filings/0001041368-26-000003.md) | [(0.1) d](/filings/0001041368-26-000007.md) | [(0.7)](/filings/0001104659-26-096729.md) | [16.8 d](/filings/0001041368-25-000004.md) | [(0.5) d](/filings/0001041368-26-000003.md) | [(3.5) d](/filings/0001041368-26-000007.md) | [2.0](/filings/0001104659-26-096729.md) |
| Capital expenditure | $m | [1.4 d](/filings/0000939057-24-000317.md) | [0.3 d](/filings/0000939057-25-000048.md) | [1.8 d](/filings/0001041368-26-000007.md) | [0.1](/filings/0000939057-25-000203.md) | [2.2 d](/filings/0001041368-25-000004.md) | [0.3 d](/filings/0001041368-26-000003.md) | [0.1 d](/filings/0001041368-26-000007.md) | [0.1](/filings/0001104659-26-096729.md) | [0.4 d](/filings/0001041368-25-000004.md) | [0.2 d](/filings/0001041368-26-000003.md) | [0.1 d](/filings/0001041368-26-000007.md) | [0.2](/filings/0001104659-26-096729.md) |
| Dividends paid | $m | [1.3 d](/filings/0000939057-24-000317.md) | [1.3 d](/filings/0000939057-25-000048.md) | [1.3 d](/filings/0001041368-26-000007.md) | [1.3](/filings/0000939057-25-000203.md) | [0.4 d](/filings/0001041368-25-000004.md) | [0.4 d](/filings/0001041368-26-000003.md) | [0.4 d](/filings/0001041368-26-000007.md) | [0.4](/filings/0001104659-26-096729.md) | [0.4 d](/filings/0001041368-25-000004.md) | [0.4 d](/filings/0001041368-26-000003.md) | [0.4 d](/filings/0001041368-26-000007.md) | [0.4](/filings/0001104659-26-096729.md) |
| Share repurchases | $m | [0.0 d](/filings/0000939057-24-000317.md) | [0.0 d](/filings/0000939057-25-000048.md) | [0.0 d](/filings/0001041368-26-000007.md) | not reported | not reported | not reported | [0.9 d](/filings/0001041368-26-000007.md) | not reported | not reported | [1.2 d](/filings/0001041368-26-000003.md) | [0.7 d](/filings/0001041368-26-000007.md) | [1.7](/filings/0001104659-26-096729.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.6](/filings/0000939057-23-000343.md) | [21.5](/filings/0000939057-24-000051.md) | [21.1](/filings/0000939057-24-000208.md) | [21.2](/filings/0000939057-24-000317.md) | [21.1](/filings/0000939057-25-000048.md) | [21.1](/filings/0000939057-25-000203.md) | [21.1](/filings/0001041368-25-000004.md) | [21.0](/filings/0001041368-26-000003.md) | [21.0](/filings/0001104659-26-096729.md) | [20.9](/filings/0001041368-25-000004.md) | [20.8](/filings/0001041368-26-000003.md) | [20.4](/filings/0001104659-26-096729.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,953,186 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-096729.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.